Skip to main navigation Skip to search Skip to main content

A Phase II Single Arm Trial of BIBW 2992 in Non Small Cell Lung Cancer Patients with Activating EGFR Mutations

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date11/29/07 → 11/30/12

Funding

  • Boehringer Ingelheim Pharmaceutical: $25,680.67